Literature DB >> 9398650

Intronic sequences are involved in neural targeting of human dopamine transporter gene expression.

A P Kouzmenko1, A M Pereira, B S Singh.   

Abstract

Dopamine transporter (DAT) plays a key role in terminating synaptic dopaminergic transmission. DAT acts exclusively on the plasma membrane of presynaptic dopaminergic neurons and DAT gene is an appropriate model for the study of dopaminergic neuron-specific regulation of gene activity. DAT represents an important target for widely used neuroleptic drugs and psychostimulants and for catecholamine-selective neurotoxins. Functional abnormalities of DAT have been implicated in diverse neurologic and psychiatric disorders. Understanding the mechanisms regulating human DAT gene activity is an important step towards elucidation of the molecular bases of a number of disorders and psychostimulant drug abuse and dependence. In this study we have cloned and characterised a 7-kb segment of the human DAT gene which includes at least 4 kb of its 5'-flanking region, localised its essential, or core-promoter, and identified the region involved in regulation of DAT neurospecific expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398650     DOI: 10.1006/bbrc.1997.7754

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Identification of an intronic cis-acting element in the human dopamine transporter gene.

Authors:  Ying Zhao; Yanhong Zhou; Nian Xiong; Zhicheng Lin
Journal:  Mol Biol Rep       Date:  2011-12-13       Impact factor: 2.316

2.  Lack of association between the -839C/T polymorphism in the SLC6A3 gene promoter and schizophrenia in the Iranian population.

Authors:  Hamid Galehdari; Shiva Hosseini; Ali Mohammad Foroughmand; Mohsen Musaviun; Saeedreza Khatami; Atefeh Pooryasin; Tahereh Ajam; Maryam Haidari
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

3.  Genomic organization and comparative sequence analysis of the mouse and human FRS2, FRS3 genes.

Authors:  Li Zhou; Kathryn McDougall; Christopher J Kubu; Joseph M Verdi; Susan O Meakin
Journal:  Mol Biol Rep       Date:  2003-03       Impact factor: 2.316

4.  Family-based study of markers at the 5'-flanking region of the human dopamine transporter gene reveals potential association with schizophrenic psychoses.

Authors:  Gerald Stöber; Julia Sprandel; Burkhard Jabs; Bruno Pfuhlmann; Kerstin Möller-Ehrlich; Michael Knapp
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

5.  Epigenetic Regulation of Dopamine Transporter mRNA Expression in Human Neuroblastoma Cells.

Authors:  Ashley L Green; Muhammad M Hossain; Siew C Tee; Helmut Zarbl; Grace L Guo; Jason R Richardson
Journal:  Neurochem Res       Date:  2015-05-12       Impact factor: 3.996

6.  Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.

Authors:  Ashley L Green; Le Zhan; Aseel Eid; Helmut Zarbl; Grace L Guo; Jason R Richardson
Journal:  Neuropharmacology       Date:  2017-07-22       Impact factor: 5.250

7.  Intragenic Transcriptional cis-Antagonism Across SLC6A3.

Authors:  Ying Zhao; Jinlong Yu; Juan Zhao; Xiaowu Chen; Nian Xiong; Tao Wang; Hong Qing; Zhicheng Lin
Journal:  Mol Neurobiol       Date:  2018-09-27       Impact factor: 5.590

8.  Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1).

Authors:  Jonathan Mill; Philip Asherson; Ian Craig; Ursula M D'Souza
Journal:  BMC Genet       Date:  2005-01-31       Impact factor: 2.797

9.  Presence of recombination hotspots throughout SLC6A3.

Authors:  Juan Zhao; Yanhong Zhou; Nian Xiong; Hong Qing; Tao Wang; Zhicheng Lin
Journal:  PLoS One       Date:  2019-06-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.